연구동향 분석
박사

암 치료전략 개선을 위한 종양세포와 주변인자와의 상호작용을 고려한 이종이식암 모델 구축 = Establishment of xenograft model considering interactions between tumor cells and adjacent factors for improvement of cancer treatment strategy

김경미 2020년

논문상세정보
인용/피인용
' 암 치료전략 개선을 위한 종양세포와 주변인자와의 상호작용을 고려한 이종이식암 모델 구축 = Establishment of xenograft model considering interactions between tumor cells and adjacent factors for improvement of cancer treatment strategy' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Artemin
  • GPER
  • 내피집락형성세포
  • 대장암
  • 맞춤의학
  • 삼중음성유방암
  • 에스트로겐
  • 오가노이드
  • 위암
  • 이종이식암 모델
  • 전이암
  • 크리신-나노입자
  • 함암 효능 평가 시스템
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
241 0

0.0%

' 암 치료전략 개선을 위한 종양세포와 주변인자와의 상호작용을 고려한 이종이식암 모델 구축 = Establishment of xenograft model considering interactions between tumor cells and adjacent factors for improvement of cancer treatment strategy' 의 참고문헌

  • xenopatients ” ) identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer
    1 ( 6 ) : p. 508-523 . [2011]
  • the non-classical membrane G protein related estrogen receptor , is overexpressed in human seminoma and promotes seminoma cell proliferation .
    7 ( 4 ) : p. e34672 . [2012]
  • prognostic and therapeutic targets of microRNAs in human gastricCancerp. 945
    17 ( 6 [2016]
  • p27 downregulation and metallothionein overexpression in gastric cancer patients are associated with a poor survival rate .
    93 ( 3 ) : p. 241-252 . [2006]
  • obesity and gastric cancer risk : results from a meta-analysis of cohort studies
    45 ( 16 ) : p. 2867-73 . [2009]
  • miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3
    9 ( 7 ) : p. 824-833 . [2011]
  • miR-223 regulates migration and invasion by targeting Artemin in human esophageal carcinoma
    18 : p. 24 . [2011]
  • fibrin and PuraMatrix matrices provide permissive environments for human endothelial and mesenchymal progenitor cells to form neovascular networks
    5 ( 4 ) : p. e74-86 . [2011]
  • bone marrow-derived endothelial progenitor cells and proangiogenic hematopoietic cells in cancer : From biology to therapy
    69 ( 2 ) : p. 108-124 . [2009]
  • al. , Function of G-Protein-Coupled Estrogen Receptor-1 in Reproductive System Tumors
    p. 7128702 . [2016]
  • al. , Estrogen regulates Hippo signaling via GPER in breast cancer
    125 ( 5 ) : p. 2123-35 [2015]
  • al. , Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV-Cripto-1 transgenic mice .
    201 ( 2 ) : p. 266-76 . [2004]
  • al. , Downregulation of G Protein-Coupled Estrogen Receptor ( GPER ) is Associated with Reduced Prognosis in Patients with Gastric Cancer
    25 : p. 3115-3126 [2019]
  • Urinary endogenous sex hormone levels and the risk of postmenopausal breast cancer
    88 ( 9 ) : p. 1394-1399 . [2003]
  • Tumorgrafts as in vivo surrogates for women with ovarian cancer
    20 ( 5 ) : p. 1288-1297 . [2014]
  • Tumor Organoids as a Pre-clinical Cancer Model for Drug Discovery
    24 ( 9 ) : p. 1092-1100 . [2017]
  • Triple-negative breast cancer : clinical features and patterns of recurrence .
    13 ( 15 Pt 1 ) : p. 4429-34 . [2007]
  • Triple-negative breast cancer
    363 ( 20 ) : p. 1938-48 . [2010]
  • Transient and sustained ERK phosphorylation and nuclear translocation in growth control
    192 ( 2 ) : p. 151-159 . [2002]
  • Therapeutic Potential of Human-Derived Endothelial Colony-Forming Cells in Animal Models
    22 ( 5 ) : p. 371-382 . [2016]
  • The third dimension bridges the gap between cell culture and live tissue .
    8 ( 10 ) : p. 839 [2007]
  • The sex ratio in gastric cancer and hypothetical considerations relative to aetiology
    22 ( 2 ) : p. 163-72 [1968]
  • The phosphoinositide 3-kinase pathway
    296 ( 5573 ) : p. 1655-1657 . [2002]
  • The phosphatidylinositol 3kinase/Akt and c-Jun N-terminal kinase signaling in cancer : Alliance or contradiction ?
    47 ( 2 ) : p. 429- 436 [2015]
  • The functional contrariety of JNK .
    46 ( 8 ) : p. 591-598 [2007]
  • The direct effect of estrogen on cell viability and apoptosis in human gastric cancer cells
    395 ( 1- 2 ) : p. 99-107 . [2014]
  • The changing global patterns of female breast cancer incidence and mortality .
    6 ( 6 ) : p. 229-39 . [2004]
  • The JNK signal transduction pathway
    19 ( 2 ) : p. 142-9 [2007]
  • The Generation and Application of Patient-Derived Xenograft Model for Cancer Research
    50 ( 1 ) : p. 1-10 [2018]
  • The G-protein-coupled estrogen receptor GPER in health and disease
    7 ( 12 ) : p. 715-26 [2011]
  • The G protein-coupled receptor GPR30 mediates the proliferative and invasive effects induced by hydroxytamoxifen in endometrial cancer cells
    420 ( 2 ) : p. 343-349 . [2012]
  • The ERK and JNK pathways in the regulation of metabolic reprogramming .
    38 ( 13 ) : p. 2223-2240 . [2019]
  • Targeting the PI3K-Akt pathway in human cancer : rationale and promise
    4 ( 4 ) : p. 257-262 . [2003]
  • Targeting aromatase and estrogen signaling in human non-small cell lung cancer .
    [2009]
  • TGF-β promotes invasion and metastasis of gastric cancer cells by increasing fascin1 expression via ERK and JNK signal pathways
    41 ( 8 ) : p. 648-656 . [2009]
  • Sustained ERK activation is involved in the kaempferol-induced apoptosis of breast cancer cells and is more evident under 3-D culture condition
    7 ( 7 ) : p. 1080-1089 . [2008]
  • Smoking and gastricCancer : systematic review and meta-analysis ofCohort studies .
    19 ( 7 ) : p. 689-701 . [2008]
  • Sex hormones , hormonal interventions , and gastricCancer risk : a meta-analysis .
    21 ( 1 ) : p. 20-38 . [2012]
  • Sex Disparity in GastricCancer : Female Sex is a Poor Prognostic Factor for Advanced GastricCancer
    23 ( 13 ) : p. 4344-4351 . [2016]
  • Serum Testosterone : Estradiol Ratio and the Development of HepatocellularCarcinoma among MaleCirrhotic Patients
    60 ( 18 ) : p. 5106-5110 . [2000]
  • Self-formation of layered neural structures in three-dimensionalCulture of ESCells
    22 ( 5 ) : p. 768-77 . [2012]
  • Role of GPER on proliferation , migration and invasion in ligand-independent manner in human ovarianCancerCell line SKOV3 .
    33 ( 8 ) : p. 552-9 . [2015]
  • Rescue surgery for unresectableColorectal liver metastases downstaged byChemotherapy : a model to predict long-term survival
    240 ( 4 ) : p. 644-57 ; discussion 657-8 [2004]
  • Repeated observation of breast tumor subtypes in independent gene expression data sets .
    100 ( 14 ) : p. 8418-23 . [2003]
  • Rapid onset of perfused blood vessels after implantation of ECFCs and MPCs inCollagen , PuraMatrix and fibrin provisional matrices
    9 ( 5 ) : p. 632-6 . [2015]
  • Progress in the treatment of advanced gastricCancer
    39 ( 7 ) : p. 1010428317714626 [2017]
  • Pro-matrix metalloproteinase-2 transfection increases orthotopic primary growth and experimental metastasis of MDA-MB-231 human breastCancerCells in nude mice
    64 ( 2 ) : p. 652-8 . [2004]
  • Positive association of up-regulatedCripto-1 and down-regulated E-cadherin with tumour progression and poor prognosis in gastricCancer
    52 ( 5 ) : p. 560-8 . [2008]
  • Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine
    7 ( 5 ) : p. 462-477 [2017]
  • Patient-derived xenografts of non small cell lung cancer : resurgence of an old model for investigation of modern concepts of tailored therapy and cancer stem cells
    [2012]
  • Patient-derived xenografts : a relevant preclinical model for drug development
    35 ( 1 ) : p. 189 [2016]
  • Patient-derived xenograft models : An emerging platform for translational cancer research .
    4 ( 9 ) : p. 998-1013 . [2014]
  • Patient-derived tumour xenografts as models for oncology drug development
    9 ( 6 ) : p. 338 [2012]
  • Patient-derived tumor xenografts : transforming clinical samples into mouse models
    73 ( 17 ) : p. 5315-9 [2013]
  • Organoids as an in vitro model of human development and disease
    18 ( 3 ) : p. 246-254 [2016]
  • Organoid modeling for cancer precision medicine
    7 ( 1 ) : p. 32 . [2015]
  • Organoid cultures derived from patients with advanced prostate cancer
    159 ( 1 ) : p. 176-187 [2014]
  • Organoid Models of Human and Mouse Ductal Pancreatic Cancer
    160 ( 1-2 ) : p. 324-338 [2015]
  • Organogenesis in a dish : modeling development and disease using organoid technologies
    345 ( 6194 ) : p. 1247125 [2014]
  • Oesophageal and gastric intestinal-type adenocarcinomas show the same male predominance due to a 17 year delayed development in females
    58 ( 1 ) : p. 16-23 . [2009]
  • Neurotrophic artemin promotes motility and invasiveness of MIA PaCa-2 pancreatic cancer cells
    13 ( 5 ) : p. 1793-7 . [2012]
  • NIH to balance sex in cell and animal studies
    509 ( 7500 ) : p. 282-3 [2014]
  • Molecular Prognostic Factors in Gastric Cancer
    p. 109 [2017]
  • Modeling of Patient-Derived Xenografts in Colorectal Cancer
    16 ( 7 ) : p. 1435- 1442 . [2017]
  • Modeling mouse and human development using organoid cultures
    142 ( 18 ) : p. 3113-3125 [2015]
  • Modeling Development and Disease with Organoids
    165 ( 7 ) : p. 1586-1597 [2016]
  • MicroRNA-223 promotes tumor progression in lung cancer A549 cells via activation of the NF-κB signaling pathway
    24 ( 6 ) : p. 405-413 [2016]
  • Metallothionein-3 Increases Triple-Negative Breast Cancer Cell Invasiveness via Induction of Metalloproteinase Expression .
    10 ( 5 ) : p. e0124865 . [2015]
  • Metallothionein isoform 3 expression in the human prostate and cancer-derived cell lines
    41 ( 3 ) : p. 196-202 . [1999]
  • Metallothionein : the multipurpose protein .
    59 ( 4 ) : p. 627-647 . [2002]
  • Metallothionein 3 : An androgen-upregulated gene enhances cell invasion and tumorigenesis of prostate carcinoma cells
    73 ( 14 ) : p. 1495-1506 . [2013]
  • Menstrual and reproductive factors and gastric cancer risk in a large prospective study of women
    56 ( 12 ) : p. 1671-1677 [2007]
  • Matrix metalloproteinases in tumor invasion and metastasis
    10 ( 6 ) : p. 415-33 . [2000]
  • Matrix metalloproteinases as emerging targets in anticancer therapy : status and prospects
    4 ( 5 ) : p. 609-633 . [2000]
  • MMP-13 stimulates osteoclast differentiation and activation in tumour breast bone metastases .
    13 ( 5 ) : p. R105 . [2011]
  • MMP-1 and Pro-MMP-10 as potential urinary pharmacodynamic biomarkers of FGFR3-targeted therapy in patients with bladder cancer
    20 ( 24 ) : p. 6324-35 . [2014]
  • Long-term expansion of epithelial organoids from human colon , adenoma , adenocarcinoma , and Barrett 's epithelium .
    141 ( 5 ) : p. 1762-1772 . [2011]
  • Junttila , and F.J. de Sauvage , Translational value of mouse models in oncology drug development
    21 ( 5 ) : p. 431-9 . [2015]
  • JAK2/STAT3 signaling pathway activation mediates tumor angiogenesis by upregulation of VEGF and bFGF in non-smallcell lung cancer .
    73 ( 3 ) : p. 366-374 . [2011]
  • Inhibition of the JAK2/STAT3 Pathway Reduces Gastric Cancer Growth In Vitro and In Vivo
    9 ( 5 ) : p. e95993 [2014]
  • In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis
    35 ( 6 ) : p. 569 [2017]
  • Improved chemotherapeutic efficacy of injectable chrysin encapsulated by copolymer nanoparticles
    12 : p. 1917-1925 . [2017]
  • Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
    121 ( 7 ) : p. 2750- 2767 [2011]
  • Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood
    104 ( 9 ) : p. 2752-60 [2004]
  • IL-6 regulates MMP-10 expression via JAK2/STAT3 signaling pathway in a human lung adenocarcinoma cell line
    29 ( 11 ) : p. 4497-501 [2009]
  • Hypermethylation of metallothionein-3 CpG island in gastric carcinoma
    24 ( 1 ) : p. 25-29 . [2003]
  • Human tumor xenografts as predictive preclinical models for anticancer drug activity in humans : better than commonly perceived—but they can be improved
    2 ( sup1 ) : p. 133-138 [2003]
  • Hepatocellular carcinoma in alcoholic cirrhosis : is sex hormone imbalance a pathogenetic factor ?
    7 ( 2 ) : p. 145-50 . [1995]
  • Habitual salt intake and risk of gastric cancer : a metaanalysis of prospective studies
    31 ( 4 ) : p. 489-98 . [2012]
  • Genetic prognostic and predictive markers in colorectal cancer
    9 ( 7 ) : p. 489 . [2009]
  • Gene-expression signatures can distinguish gastric cancer grades and stages
    6 ( 3 ) : p. e17819 . [2011]
  • Gender Effect in Experimental Models of Human Medulloblastoma : Does the Estrogen Receptor β Signaling Play a Role ?
    9 ( 7 ) : p. e101623 [2014]
  • Gender Difference in Distribution of Estrogen and Androgen Receptors in Intestinal-type Gastric Cancer
    37 ( 1 ) : p. 197-202 [2017]
  • GPR30/GPER1 : searching for a role in estrogen physiology .
    20 ( 8 ) : p. 409-16 . [2009]
  • GPER-1 acts as a tumor suppressor in ovarian cancer
    6 ( 1 ) : p. 51 . [2013]
  • GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells .
    133 ( 3 ) : p. 1025-1035 . [2012]
  • GPER functions as a tumor suppressor in triplenegative breast cancer cells
    140 ( 5 ) : p. 713-23 . [2014]
  • GFRA3 promoter methylation may be associated with decreased postoperative survival in gastric cancer .
    16 ( 1 ) : p. 225 . [2016]
  • G-Protein Coupled Estrogen Receptor in Breast Cancer
    20 ( 2 ) [2019]
  • G protein-coupled estrogen receptor regulates mammary tumorigenesis and metastasis
    12 ( 11 ) : p. 1644-1654 . [2014]
  • G protein-coupled estrogen receptor deficiency accelerates liver tumorigenesis by enhancing inflammation and fibrosis
    382 ( 2 ) : p. 195-202 [2016]
  • G Protein–Coupled Receptor 30 ( GPR30 ) Mediates Gene Expression Changes and Growth Response to 17β-Estradiol and Selective GPR30 Ligand G-1 in Ovarian Cancer Cells
    67 ( 4 ) : p. 1859-1866 . [2007]
  • Frondoside A has an anti-invasive effect by inhibiting TPA-induced MMP-9 activation via NF-kappaB and AP-1 signaling in human breast cancer cells
    41 ( 3 ) : p. 933-40 . [2012]
  • Extrinsic regulators of epithelial tumor progression : metalloproteinases
    10 ( 1 ) : p. 120-7 . [2000]
  • Expression of metallothionein-III in patients with non-small cell lung cancer .
    33 ( 3 ) : p. 965-74 . [2013]
  • Expression of matrix metalloproteinases in human breast cancer tissues
    34 ( 6 ) : p. 395-405 . [2013]
  • Expression of estrogen receptor-α and -β mRNAs in human gastric cancer
    176 ( 2 ) : p. 129-135 . [2002]
  • Exploring protocol for breast cancer xenograft model using endothelial colony-forming cells
    7 ( 5 ) : p. 1228-1234 . [2018]
  • Evolving treatment of advanced colon cancer
    60 : p. 207-219 . [2009]
  • Estrogenic transmembrane receptor of GPR30 mediates invasion and carcinogenesis by endometrial cancer cell line RL95-2 .
    138 ( 5 ) : p. 775-83 . [2012]
  • Estimates of worldwide burden of cancer in 2008 : GLOBOCAN 2008. International journal of cancer
    127 ( 12 ) : p. 2893-2917 . [2010]
  • Eps8 regulates cellular proliferation and migration of breast cancer
    46 ( 1 ) : p. 205-14 . [2015]
  • Epidemiologic trends in esophageal and gastric cancer in the United States
    11 ( 2 ) : p. 235-56 [2002]
  • Enigmatic sex disparities in cancer incidence
    27 ( 3 ) : p. 187-96 . [2012]
  • Endothelial progenitor cell biology in disease and tissue regeneration
    4 : p. 24 . [2011]
  • Endogenous Estrogen , Androgen , and Progesterone Concentrations and Breast Cancer Risk Among Postmenopausal Women .
    96 ( 24 ) : p. 1856-1865 . [2004]
  • Emerging roles of GPER in diabetes and atherosclerosis
    26 ( 4 ) : p. 185-92 . [2015]
  • Emerging Utilization of Chrysin Using Nanoscale Modification
    p. 7 . [2016]
  • Effects of 17β-estradiol and tamoxifen on gastric cancer cell proliferation and apoptosis and ER-α36 expression
    13 ( 1 ) : p. 57-62 . [2017]
  • ER‑α36‑mediated gastric cancer cell proliferation via the c‑Src pathway
    6 ( 2 ) : p. 329-335 . [2013]
  • Do cell lines in vitro reflect the properties of the tumours of origin ? A study of lines derived from human melanoma xenografts .
    44 ( 6 ) : p. 775-786 [1981]
  • Distant metastasis in triple-negative breast cancer
    60 ( 3 ) : p. 290-4 . [2013]
  • Development of an integrated genomic classifier for a novel agent in colorectal cancer : approach to individualized therapy in early development
    16 ( 12 ) : p. 3193-3204 [2010]
  • Delayed rise in incidence of gastric cancer in females results in unique sex ratio ( M/F ) pattern : etiologic hypothesis
    5 ( 4 ) : p. 213-9 . [2002]
  • Deconstructing the third dimension : how 3D culture microenvironments alter cellular cues .
    125 ( 13 ) : p. 3015-3024 . [2012]
  • Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients
    7 ( 31 ) : p. 49322-49333 . [2016]
  • Cripto-1-induced increase in vimentin expression is associated with enhanced migration of human Caski cervical carcinoma cells
    257 ( 1 ) : p. 223-9 [2000]
  • Cripto : a novel epidermal growth factor ( EGF ) -related peptide in mammary gland development and neoplasia
    21 ( 1 ) : p. 61-70 . [1999]
  • Comparison of 3D and 2D tumor models reveals enhanced HER2 activation in 3D associated with an increased response to trastuzumab
    28 ( 3 ) : p. 461 . [2009]
  • Clonogenic assay with established human tumour xenografts : correlation of in vitro to in vivo activity as a basis for anticancer drug discovery
    40 ( 6 ) : p. 802-820 [2004]
  • Clinical predictive value of the in vitro cell line , human xenograft , and mouse allograft preclinical cancer models
    9 ( 11 ) : p. 4227-39 . [2003]
  • Chrysin inhibits metastatic potential of human triplenegative breast cancer cells by modulating matrix metalloproteinase-10 , epithelial to mesenchymal transition , and PI3K/Akt signaling pathway
    34 ( 1 ) : p. 105-12 . [2014]
  • Chrysin Increases the Therapeutic Efficacy of Docetaxel and Mitigates Docetaxel-Induced Edema
    16 ( 4 ) : p. 496-504 . [2017]
  • Childhood cancer registrations in the developing world : still more boys than girls
    91 ( 3 ) : p. 402-6 . [2001]
  • Characterization of a large panel of patient-derived tumor xenografts representing the clinical heterogeneity of human colorectal cancer
    18 ( 19 ) : p. 5314-5328 [2012]
  • Cellular function of phosphoinositide 3-kinases : implications for development , immunity , homeostasis , and cancer
    17 ( 1 ) : p. 615-675 . [2001]
  • Capturing complex 3D tissue physiology in vitro
    7 ( 3 ) : p. 211-24 [2006]
  • Cancer panel analysis of circulating tumor cells in patients with breast cancer
    16 ( 1 ) : p. 612-618 . [2018]
  • Cancer gene panel analysis of cultured circulating tumor cells and primary tumor tissue from patients with breast cancer
    13 ( 6 ) : p. 4627-4632 [2017]
  • Cancer cell lines for drug discovery and development
    74 ( 9 ) : p. 2377-2384 . [2014]
  • Breast and renal cancer—Derived endothelial colony forming cells share a common gene signature .
    77 : p. 155-164 . [2017]
  • Artemin-stimulated progression of human non-small cell lung carcinoma is mediated by BCL2 .
    9 ( 6 ) : p. 1697-708 . [2010]
  • Artemin stimulates oncogenicity and invasiveness of human endometrial carcinoma cells
    151 ( 3 ) : p. 909-20 . [2010]
  • Artemin promotes proliferation and metastasis in human laryngeal squamous cell carcinoma
    10 ( 10 ) : p. 10413- 10418 [2017]
  • Artemin is oncogenic for human mammary carcinoma cells
    28 ( 19 ) : p. 2034-45 . [2009]
  • Artemin is hypoxia responsive and promotes oncogenicity and increased tumor initiating capacity in hepatocellular carcinoma
    7 ( 3 ) : p. 3267-82 . [2016]
  • Anti-tumor efficacy of fulvestrant in estrogen receptor positive gastric cancer
    4 : p. 7592-7592 . [2014]
  • Analysis of demographic characteristics in 3242 young age gastric cancer patients in Korea
    16 ( 2 ) : p. 256-63 . [2010]
  • An anticancer agent icaritin induces sustained activation of the extracellular signal-regulated kinase ( ERK ) pathway and inhibits growth of breast cancer cells
    658 ( 2-3 ) : p. 114-122 [2011]
  • Additional MDA-MB-231 breast cancer cell matrix metalloproteinases promote invasiveness .
    216 ( 2 ) : p. 480-5 . [2008]
  • Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NFkappaB/IL-6 signals
    386 : p. 12-23 . [2017]
  • Activation of GPER suppresses epithelial mesenchymal transition of triple negative breast cancer cells via NF-κB signals
    10 ( 6 ) : p. 775-788 . [2016]
  • Activation of GPER suppresses epithelial mesenchymal transition of triple negative breast cancer cells via NF-kappaB signals
    10 ( 6 ) : p. 775-88 . [2016]
  • Activation of G-Protein-Coupled Estrogen Receptor Inhibits the Migration of Human Nonsmall Cell Lung Cancer Cells via IKK-beta/NF-kappaB Signals
    35 ( 8 ) : p. 434-42 [2016]
  • Activation of G protein coupled estrogen receptor ( GPER ) promotes the migration of renal cell carcinoma via the PI3K/AKT/MMP-9 signals
    12 ( 2 ) : p. 109-117 . [2018]
  • Acidic preconditioning of endothelial colony-forming cells ( ECFC ) promote vasculogenesis under proinflammatory and high glucose conditions in vitro and in vivo
    9 ( 1 ) : p. 120-120 [2018]
  • Absence of metallothionein 3 expression in breast cancer is a rare but favorable marker that is under epigenetic control .
    92 ( 9 ) : p. 1673-1695 . [2010]
  • ARTEMIN synergizes with TWIST1 to promote metastasis and poor survival outcome in patients with ER negative mammary carcinoma
    13 ( 6 ) : p. R112 . [2011]
  • A sex-dimorphic mouse model of esophageal squamous cell carcinoma
    9 ( 2 ) : p. 429-433 . [2019]
  • A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro
    69 ( 8 ) : p. 3364-3373 . [2009]
  • A pilot clinical study of treatment guided by personalized tumorgrafts in patients with advanced cancer
    10 ( 8 ) : p. 1311-1316 [2011]
  • A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas .
    348 ( 6303 ) : p. 699- 704 . [1990]
  • A meta-analysis on alcohol drinking and gastric cancer risk
    23 ( 1 ) : p. 28-36 . [2012]
  • A flavonoid chrysin suppresses hypoxic survival and metastatic growth of mouse breast cancer cells
    30 ( 5 ) : p. 2357-64 . [2013]
  • A Colorectal Tumor Organoid Library Demonstrates Progressive Loss of Niche Factor Requirements during Tumorigenesis .
    18 ( 6 ) : p. 827-838 . [2016]
  • 86. Kretzschmar, K. and H. Clevers, Organoids: Modeling Development and the Stem Cell Niche in a Dish. Developmental Cell, 2016. 38(6): p. 590- 600.
  • 80. Torre, L.A., et al., Global cancer statistics, 2012. CA Cancer J Clin, 2015. 65(2): p. 87-108.
  • 79. Siegel, R.L., K.D. Miller, and A. Jemal, Cancer Statistics, 2017. CA Cancer J Clin, 2017. 67(1): p. 7-30.
    67 ( 1 ) : p. 7-30 . [2017]
  • 7. Siegel, R.L., K.D. Miller, and A. Jemal, Cancer statistics, 2018. CA Cancer J Clin, 2018. 68(1): p. 7-30.
    68 ( 1 ) : p. 7-30 . [2018]
  • 58. Verstovsek, S., Janus-activated kinase 2 inhibitors: a new era of targeted therapies providing significant clinical benefit for Philadelphia chromosome-negative myeloproliferative neoplasms. J Clin Oncol, 2011. 29(7): p. 781-3.
  • 30. Filardo, E.J., A role for G-protein coupled estrogen receptor (GPER) in estrogen-induced carcinogenesis: Dysregulated glandular homeostasis, survival and metastasis. J Steroid Biochem Mol Biol, 2018. 176: p. 38-48.
  • 3. Chandanos, E. and J. Lagergren, The mystery of male dominance in oesophageal cancer and the potential protective role of oestrogen. Eur J Cancer, 2009. 45(18): p. 3149-55.
  • 183. Chang, Y.-M., et al., RSC96 Schwann cell proliferation and survival induced by dilong through PI3K/Akt signaling mediated by IGF-I. Evidence-Based Complementary and Alternative Medicine, 2011. 2011.
  • 17beta-estradiol-induced growth of triple-negative breast cancer cells is prevented by the reduction of GPER expression after treatment with gefitinib .
    37 ( 2 ) : p. 1212-1218 . [2017]
  • 17beta-estradiol and tamoxifen prevent gastric cancer by modulating leukocyte recruitment and oncogenic pathways in Helicobacter pylori-infected INS-GAS male mice
    4 ( 9 ) : p. 1426-35 . [2011]
  • 167. Filardo, E.J., et al., Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol, 2002. 16(1): p. 70-84.
  • 157. Lappano, R. and M. Maggiolini, G protein-coupled receptors: novel targets for drug discovery in cancer. Nat Rev Drug Discov, 2011. 10(1): p. 47-60.
  • 140. Aydiner, A., et al., MAPK overexpression is associated with anthracycline resistance and increased risk for recurrence in patients with triple-negative breast cancer. Annals of Oncology, 2007. 19(4): p. 669-674.
  • 139. DeSantis, C., et al., Breast cancer statistics, 2011. CA Cancer J Clin, 2011. 61(6): p. 409-18.